Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes

Circ Res. 2005 Feb 4;96(2):180-8. doi: 10.1161/01.RES.0000152968.71868.c3. Epub 2004 Dec 9.

Abstract

Upregulation of the sympathetic nervous system plays a key role in the pathogenesis of insulin resistance. Although the heart is a target organ of insulin, few studies have examined the mechanisms by which beta-adrenergic stimulation affects insulin sensitivity in cardiac muscle. In this study, we explored the molecular mechanisms involved in the regulation of the cross-talk between beta adrenergic and insulin receptors in neonatal rat cardiomyocytes and in transgenic mice with cardiac overexpression of a constitutively active mutant of Akt (E40K Tg). The results of this study show that beta-adrenergic receptor stimulation has a biphasic effect on insulin-stimulated glucose uptake. Short-term stimulation induces an additive effect on insulin-induced glucose uptake, and this effect is mediated by phosphorylation of Akt in threonine 308 through PKA/Ca2+-dependent and PI3K-independent pathway, whereas insulin-evoked threonine phosphorylation of Akt is exclusively PI3K-dependent. On the other hand, long-term stimulation of beta-adrenergic receptors inhibits both insulin-stimulated glucose uptake and insulin-induced autophosphorylation of the insulin receptor, and at the same time promotes threonine phosphorylation of the insulin receptor. This is mediated by serine 473 phosphorylation of Akt through PKA/Ca2+ and PI3K-dependent pathways. Under basal conditions, E40K Tg mice show increased levels of threonine phosphorylation of the beta subunit of the insulin receptor and blunted tyrosine autophosphorylation of the beta-subunit of the insulin receptor after insulin stimulation. These results indicate that, in cardiomyocytes, beta-adrenergic receptor stimulation impairs insulin signaling transduction machinery through an Akt-dependent pathway, suggesting that Akt is critically involved in the regulation of insulin sensitivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Adrenergic beta-Agonists / toxicity
  • Amino Acid Substitution
  • Animals
  • Animals, Newborn
  • Cells, Cultured / drug effects
  • Cells, Cultured / metabolism
  • Cyclic AMP-Dependent Protein Kinases / physiology
  • Deoxyglucose / metabolism
  • Enzyme Activation
  • Insulin Resistance / physiology*
  • Isoproterenol / pharmacology
  • Isoproterenol / toxicity
  • Mice
  • Mice, Transgenic
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Phosphatidylinositol 3-Kinases / physiology
  • Phosphorylation
  • Phosphoserine / metabolism*
  • Phosphothreonine / metabolism*
  • Protein Processing, Post-Translational / drug effects
  • Protein Processing, Post-Translational / physiology*
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / physiology*
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / physiology*
  • Proto-Oncogene Proteins c-akt
  • Rats
  • Receptor Cross-Talk / drug effects
  • Receptor Cross-Talk / physiology*
  • Receptor, Insulin / physiology*
  • Receptors, Adrenergic, beta / drug effects
  • Receptors, Adrenergic, beta / physiology*
  • Signal Transduction / physiology*
  • Structure-Activity Relationship
  • Sympathetic Nervous System / physiology*

Substances

  • Adrenergic beta-Agonists
  • Proto-Oncogene Proteins
  • Receptors, Adrenergic, beta
  • Phosphothreonine
  • Phosphoserine
  • Deoxyglucose
  • Receptor, Insulin
  • Akt1 protein, rat
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Cyclic AMP-Dependent Protein Kinases
  • Isoproterenol